TrialVaccine2017

Tularemia vaccine: Safety, reactogenicity, "Take" skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain - A phase 2 randomized clinical Trial.

Mark J Mulligan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.